Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2003
06/25/2003EP1320382A2 Novel methods for inhibition of viral infection
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320375A2 Inhibition of systemic infections in humans and vertebrates by dietary fibers
06/25/2003EP1320374A1 Influenza virus binding, sialylated oligosaccharide substance and use thereof
06/25/2003EP1320371A2 Charged phospholipid compositions and methods for their use
06/25/2003EP1320363A1 Lactone integrin antagonists
06/25/2003EP1320357A1 Topical polymeric antimicrobial emulsion
06/25/2003EP1320355A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
06/25/2003EP1283709A4 Peptide deformylase inhibitors
06/25/2003EP1250343B1 Azalide antibiotic compositions
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP1112692B1 Drinks and foods capable of eliminating helicobacter pylori
06/25/2003EP1100800B1 Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors
06/25/2003EP1007006B1 Cefadroxil monohydrate tablet formulation
06/25/2003EP0975342B1 Pharmaceutical formulations comprising amoxocyllin and clavulanate
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0830141B1 Improved virus vaccines
06/25/2003EP0806957B1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc together with azt.
06/25/2003EP0678121B1 Methods and reagents for inhibiting furin endoprotease
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426418A Phosphate nucleotide compound'
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426408A Pyrimidinyl methyl indole derivatives with antibacterial activity
06/25/2003CN1426399A Process for producing quinolonecarboxylic acids and intermediates thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426309A Adjuvanted genetic vaccines
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/25/2003CN1425680A Nucleotide analogue composition and preparing method
06/25/2003CN1425673A Adefovir dipivoxil new crystal state, new crystal state composition and its preparing method
06/25/2003CN1425669A Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component
06/25/2003CN1425668A Tetracyclic fluoroquinolone carboxylic acid, its preparin method and medicinal composition with it as active component
06/25/2003CN1425652A Aporphine alkaloids with hepatitis virus inhibiting activity
06/25/2003CN1425455A Tradititional Chinese medicine preparation for curing tuberculous diseases
06/25/2003CN1425442A Wound fast heeling medicine
06/25/2003CN1425426A Medicine for curing cold and influenza and complication and its preparing process
06/25/2003CN1425418A Method for preparing 'Antidotal Decoction of Coptidis' solid preparation with combination of film and resin
06/25/2003CN1425417A Medicine for dispelling heat of liver and toxin to treat hepatitis B
06/25/2003CN1425416A Medicine for curing AIDS and its preparing method
06/25/2003CN1425413A Xiasangju effervescent tablet and its preparing process
06/25/2003CN1425401A Medicine for curing foot and skin itch
06/25/2003CN1425392A Anti-virus compound Chinese medicine and its preparing method
06/25/2003CN1425389A Natural toad skin for curing AIDS
06/25/2003CN1425383A Product of ginsenoside for curing hepatitis
06/25/2003CN1425380A Product of ginsenoside for curing AIDS
06/25/2003CN1425376A Sodium cefetaxime and sodium tazotactam compound preparation for injection
06/25/2003CN1425373A Slow-releasing kurarinol preparation and its preparing method
06/25/2003CN1425370A Nano grade anti-HIV micro ball
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/25/2003CN1112199C Exterior applied medicine for treating dermatopathy
06/25/2003CN1112194C Compound yexiazhu medicine and preparing process thereof
06/24/2003US6583311 Stable NO-delivering compounds
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583274 Crystalline forms of macrolide antibiotic
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6583265 Cyclosporins
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583149 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583136 Antifungal ethers
06/24/2003US6583133 Especially against Gram-positive organisms, e.g. methicillin-sensitive (MSSA) and methicillin- resistant (MRSA) staphylococci, enterococci and pneumococci
06/24/2003US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus
06/24/2003US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow
06/24/2003US6583119 Aromatic antibiotics such as 7-((6-deoxy-5-methyl-4-methyl-hexopyranosyl)oxy)-4-hydroxy-8-methyl-3-(1 -(phenoxyimino) ethyl)-2H-1-benzopyran-2-one (2-propynyloxy)-carbamic 3'-ester acid, for prevention of grampositive bacterial infections
06/24/2003US6583116 Preventing gramnegative bacterial infections by administering synergystic mixtures of bactericidal/permeability-increasing (BPI) proteins and antibiotics
06/24/2003US6583108 Human bikunin
06/24/2003US6582949 Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582910 WbpP and method for assay of WbpP
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/24/2003US6582717 Drug delivery composition and device
06/24/2003US6582706 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
06/24/2003US6582705 Acellular antibordetella vaccine
06/24/2003US6582704 Immunogenic peptides from the HPV E7 protein
06/24/2003US6582703 Medical diagnosis; amplification primers; genetic engineering
06/24/2003US6582699 Combination of outer-polysaccharides extracted from Brucella comprises "A" outer-polysaccharide and "M" outer-polysaccharide and "R" protein antigens.
06/24/2003CA2179015C Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/24/2003CA2012311C New protein-polycation-conjugate
06/19/2003WO2003050499A2 Use of a labeled ligand having human cd4 specificity
06/19/2003WO2003050295A2 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050241A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003WO2003050139A2 Prion inhibiting peptides and derivatives thereof
06/19/2003WO2003050132A1 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
06/19/2003WO2003050129A1 Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050124A1 Crystalline cefdinir potassium dihydrate
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050120A1 Pyrazolo-pyridine derivatives as antiherpes agents
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 1798